激素治疗和跨性别者的癌症风险:一个系统的审查
Liza Yurie Teruya Uchimura1, Tatiana Yonekura1, Mabel Fernandes Figueiró1
1Hospital do Coração, São Paulo, SP, Brazil.
概括
这次审查考察了接受激素治疗的跨性别个体的癌症风险. 目前的证据是不确定的,研究显示激素治疗和癌症发展之间的关联混合的结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 跨性别者健康 跨性别者健康
背景情况:
- 激素治疗是跨性别者性别肯定护理的关键组成部分.
- 了解包括癌症风险在内的长期健康影响对于患者安全和明智的临床决策至关重要.
研究的目的:
- 系统地审查和综合现有证据,研究在接受激素治疗的跨性别者中癌症发展的风险.
主要方法:
- 使用主要数据库 (PubMed,Embase等) 进行了快速系统审查. ) 的情况.
- 独立审查员选了研究并提取了数据.
- 使用Joanna Briggs研究所对队列和病例控制研究的检查清单来评估方法质量.
主要成果:
- 五项研究 (4个队列,1个病例控制) 被纳入了审查.
- 两项研究表明,跨性别人士的激素治疗与癌症相关的潜在风险.
- 三项研究没有发现增加癌症风险.
结论:
- 目前的文献缺乏关于激素治疗与跨性别人口癌症风险之间的关联的共识.
- 尽管研究设计严谨,但相互矛盾的结果凸显了进一步高质量的研究的必要性.
相关概念视频
Hormonal Regulation
43.1K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.1K
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Disorders of the Female Reproductive System
322
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
322
Hazard Ratio
83
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
83


